Payer+Provider's Health System Review
Plan rewarding drugmakers for new antibiotics would cost $4.5B over 10 years, analysis finds
Smith+Nephew sees strategic opportunity in ASCs
November 1, 2019
Read the full post on Becker's Hospital Review